Status:
COMPLETED
Aggressive Versus Expectant Management of Severe Preeclampsia Remote From Term
Lead Sponsor:
Complejo Hospitalario Dr. Arnulfo Arias Madrid
Conditions:
Preeclampsia
Eligibility:
FEMALE
Phase:
NA
Brief Summary
How best to manage preeclampsia remote from term is controversial because of conflicting maternal and neonatal risks. Gestational age is the most important determinant of neonatal outcome. There are t...
Detailed Description
Severa Preeclampsia between 28 and 33 weeks of gestation Women and fetus with stable condition All women receive complete dosis of steroids
Eligibility Criteria
Inclusion
- Pregnancy with severe preeclampsia and 28 to 33 weeks of gestation
Exclusion
- Uncontrollable blood pressure or persistent severe hypertension (160/110 mmHg)
- Persistent symptoms of preeclampsia
- Maternal complications (HELLP syndrome, acute renal insufficiency, cerebral edema, eclampsia, pulmonary edema)
- Fetal death, restriction of fetal grown
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT01164852
Start Date
August 1 2010
End Date
August 1 2012
Last Update
August 14 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Terodoro Maldonado, del IESS
Gauyas, Ecuador
2
Hospital Carlos Andrade Marin
Quito, Ecuador
3
Hospital de Gineco-Obstetricia del seguro social
Guatemala City, Guatemala
4
Hospital de Ginecologia del Instituto Materno Infantil
Toluca, Mexico